WO2003035895A3 - Analyse a parametres multiples d'acides nucleiques complets et de caracteristiques morphologiques sur le meme echantillon - Google Patents
Analyse a parametres multiples d'acides nucleiques complets et de caracteristiques morphologiques sur le meme echantillon Download PDFInfo
- Publication number
- WO2003035895A3 WO2003035895A3 PCT/US2002/034570 US0234570W WO03035895A3 WO 2003035895 A3 WO2003035895 A3 WO 2003035895A3 US 0234570 W US0234570 W US 0234570W WO 03035895 A3 WO03035895 A3 WO 03035895A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cells
- rare
- detection
- assay
- blood
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
- G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2550/00—Electrophoretic profiling, e.g. for proteome analysis
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2004-7006181A KR20040047971A (ko) | 2001-10-26 | 2002-10-28 | 동일 샘플상에서의 광범위 핵산 및 이의 형태학적 특질에대한 다중 매개변수 분석법 |
IL16135702A IL161357A0 (en) | 2001-10-26 | 2002-10-28 | Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample |
EP02795565A EP1438419A2 (fr) | 2001-10-26 | 2002-10-28 | Analyse a parametres multiples d'acides nucleiques complets et de caracteristiques morphologiques sur le meme echantillon |
BRPI0213520-5A BR0213520A (pt) | 2001-10-26 | 2002-10-28 | método para diagnosticar a gravidade de uma doença em um indivìduo de teste, e, kit de teste para triagem de uma amostra de paciente quanto à presença de células cancerosas circulantes |
JP2003538395A JP2005507997A (ja) | 2001-10-26 | 2002-10-28 | 同一試料についての包括的核酸および形態学的特徴のマルチパラメーター分析 |
CA002465288A CA2465288A1 (fr) | 2001-10-26 | 2002-10-28 | Analyse a parametres multiples d'acides nucleiques complets et de caracteristiques morphologiques sur le meme echantillon |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33066901P | 2001-10-26 | 2001-10-26 | |
US60/330,669 | 2001-10-26 | ||
US36994502P | 2002-04-04 | 2002-04-04 | |
US60/369,945 | 2002-04-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003035895A2 WO2003035895A2 (fr) | 2003-05-01 |
WO2003035895A3 true WO2003035895A3 (fr) | 2004-01-08 |
Family
ID=26987390
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/034397 WO2003035894A2 (fr) | 2001-10-26 | 2002-10-28 | Analyse de parametres multiples d'acides nucleiques et de caracteristiques morphologiques d'ensemble sur le meme echantillon |
PCT/US2002/034570 WO2003035895A2 (fr) | 2001-10-26 | 2002-10-28 | Analyse a parametres multiples d'acides nucleiques complets et de caracteristiques morphologiques sur le meme echantillon |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/034397 WO2003035894A2 (fr) | 2001-10-26 | 2002-10-28 | Analyse de parametres multiples d'acides nucleiques et de caracteristiques morphologiques d'ensemble sur le meme echantillon |
Country Status (9)
Country | Link |
---|---|
EP (2) | EP1438398A2 (fr) |
JP (1) | JP2005507997A (fr) |
KR (1) | KR20040047971A (fr) |
CN (1) | CN1610752A (fr) |
AU (1) | AU2002360305A1 (fr) |
BR (1) | BR0213520A (fr) |
CA (2) | CA2465274A1 (fr) |
IL (1) | IL161357A0 (fr) |
WO (2) | WO2003035894A2 (fr) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
US8168389B2 (en) | 2006-06-14 | 2012-05-01 | The General Hospital Corporation | Fetal cell analysis using sample splitting |
US8195415B2 (en) | 2008-09-20 | 2012-06-05 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
US8986966B2 (en) | 2002-09-27 | 2015-03-24 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
US9174222B2 (en) | 2005-04-05 | 2015-11-03 | The General Hospital Corporation | Devices and method for enrichment and alteration of cells and other particles |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6913697B2 (en) | 2001-02-14 | 2005-07-05 | Science & Technology Corporation @ Unm | Nanostructured separation and analysis devices for biological membranes |
US8986944B2 (en) | 2001-10-11 | 2015-03-24 | Aviva Biosciences Corporation | Methods and compositions for separating rare cells from fluid samples |
US8980568B2 (en) | 2001-10-11 | 2015-03-17 | Aviva Biosciences Corporation | Methods and compositions for detecting non-hematopoietic cells from a blood sample |
WO2003066191A1 (fr) | 2002-02-04 | 2003-08-14 | Colorado School Of Mines | Separations de particules cellulaires et colloidales par ecoulements laminaires |
WO2005040396A2 (fr) * | 2003-10-16 | 2005-05-06 | Genomic Health, Inc. | Systeme d'essai qrt-pcr pour le profilage d'expression genetique |
US7332597B2 (en) | 2004-06-28 | 2008-02-19 | University Of Kentucky Research Foundation | Primers and probe to identify mycobacterium tuberculosis complex |
ITBO20040420A1 (it) | 2004-07-07 | 2004-10-07 | Type S R L | Macchina per taglio e formatura di piattine metalliche |
DE102005013261A1 (de) * | 2005-03-22 | 2006-09-28 | Adnagen Ag | Reagenz und Verfahren zur Verhinderung der zeitabhängigen Expression in biologischen Zellen |
DE102005029808A1 (de) * | 2005-06-27 | 2007-01-04 | Siemens Ag | Trägermaterial, Verfahren zu seiner Herstellung und Verwendung |
ITBO20050481A1 (it) | 2005-07-19 | 2007-01-20 | Silicon Biosystems S R L | Metodo ed apparato per la manipolazione e/o l'individuazione di particelle |
CA2621070A1 (fr) | 2005-09-02 | 2007-03-08 | Toray Industries, Inc. | Composition et procede de diagnostic d'un cancer du rein et d'evaluation du pronostic vital d'un patient atteint de cancer du rein |
US20070059683A1 (en) * | 2005-09-15 | 2007-03-15 | Tom Barber | Veterinary diagnostic system |
US9134237B2 (en) | 2005-09-20 | 2015-09-15 | Janssen Diagnotics, LLC | High sensitivity multiparameter method for rare event analysis in a biological sample |
WO2007053245A2 (fr) | 2005-09-20 | 2007-05-10 | Immunivest Corporation | Procedes et compositions destines a produire des sondes d'adn a sequence unique, etiquetage de sonde d'adn et utilisation de ces sondes |
ITBO20050646A1 (it) | 2005-10-26 | 2007-04-27 | Silicon Biosystem S R L | Metodo ed apparato per la caratterizzazione ed il conteggio di particelle |
US9487812B2 (en) | 2012-02-17 | 2016-11-08 | Colorado School Of Mines | Optical alignment deformation spectroscopy |
US9885644B2 (en) | 2006-01-10 | 2018-02-06 | Colorado School Of Mines | Dynamic viscoelasticity as a rapid single-cell biomarker |
US9878326B2 (en) | 2007-09-26 | 2018-01-30 | Colorado School Of Mines | Fiber-focused diode-bar optical trapping for microfluidic manipulation |
US8119976B2 (en) | 2007-07-03 | 2012-02-21 | Colorado School Of Mines | Optical-based cell deformability |
ITTO20060226A1 (it) | 2006-03-27 | 2007-09-28 | Silicon Biosystem S P A | Metodo ed apparato per il processamento e o l'analisi e o la selezione di particelle, in particolare particelle biologiche |
CA2647843A1 (fr) * | 2006-04-18 | 2007-10-25 | Wellstat Biologics Corporation | Detection de proteines dans des cellules neoplasiques en circulation |
WO2007147074A2 (fr) | 2006-06-14 | 2007-12-21 | Living Microsystems, Inc. | Utilisation de génotypage snp fortement parallèle pour diagnostic fœtal |
US20080050739A1 (en) | 2006-06-14 | 2008-02-28 | Roland Stoughton | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
CN101583722A (zh) | 2006-07-14 | 2009-11-18 | 阿维瓦生物科学股份有限公司 | 从生物学样品检测稀有细胞的方法和组合物 |
JP4926812B2 (ja) * | 2007-02-01 | 2012-05-09 | シスメックス株式会社 | 血球分析装置および体液分析方法 |
US10722250B2 (en) | 2007-09-04 | 2020-07-28 | Colorado School Of Mines | Magnetic-field driven colloidal microbots, methods for forming and using the same |
ITTO20070771A1 (it) | 2007-10-29 | 2009-04-30 | Silicon Biosystems Spa | Metodo e apparato per la identificazione e manipolazione di particelle |
US10895575B2 (en) | 2008-11-04 | 2021-01-19 | Menarini Silicon Biosystems S.P.A. | Method for identification, selection and analysis of tumour cells |
IT1391619B1 (it) * | 2008-11-04 | 2012-01-11 | Silicon Biosystems Spa | Metodo per l'individuazione, selezione e analisi di cellule tumorali |
DK2408562T3 (en) | 2009-03-17 | 2018-06-06 | Menarini Silicon Biosystems Spa | Microfluidic device for isolating cells |
JP5729904B2 (ja) | 2009-06-02 | 2015-06-03 | キヤノン株式会社 | 細胞から蛋白質、dna、rnaを調製する方法 |
JP5686098B2 (ja) * | 2009-09-17 | 2015-03-18 | Jsr株式会社 | アビジンとビオチン誘導体の解離方法及び解離剤 |
EP2521778B1 (fr) * | 2010-01-04 | 2014-03-19 | QIAGEN Gaithersburg, Inc. | Procédés, compositions et kits de récupération des acides nucléiques ou des protéines dans des échantillons de tissus fixés |
EP2614160B1 (fr) | 2010-09-10 | 2016-04-06 | Bio-Rad Laboratories, Inc. | Détection des régions d'interaction de l'arn au sein de l'adn |
CN102565404B (zh) * | 2010-12-24 | 2014-04-16 | 牛刚 | 一种检测血液中游离大肠癌细胞标志物的试剂盒 |
CN102156164B (zh) * | 2011-01-13 | 2012-12-12 | 北京肿瘤医院 | 核仁磷酸蛋白可变剪接体的质谱鉴定方法和胃癌诊断试剂盒 |
CN102109525B (zh) * | 2011-01-26 | 2013-10-16 | 牛刚 | 一种检测血液中游离乳腺癌细胞标志物的试剂盒 |
EP2675913B1 (fr) | 2011-02-15 | 2016-12-14 | Bio-Rad Laboratories, Inc. | Détection de méthylation dans une sous-population d'adn génomique |
US20120252038A1 (en) * | 2011-04-01 | 2012-10-04 | Chianese David A | Steroid receptor assays |
CN103732761A (zh) | 2011-08-03 | 2014-04-16 | 伯乐实验室公司 | 使用透化处理的细胞过滤小核酸 |
ITTO20110990A1 (it) | 2011-10-28 | 2013-04-29 | Silicon Biosystems Spa | Metodo ed apparato per l'analisi ottica di particelle a basse temperature |
ITBO20110766A1 (it) | 2011-12-28 | 2013-06-29 | Silicon Biosystems Spa | Dispositivi, apparato, kit e metodo per il trattamento di un campione biologico |
WO2014067528A1 (fr) * | 2012-10-29 | 2014-05-08 | Arcedi Biotech Aps | Enrichissement et détection améliorés de cellules sanguines rares |
EP2972202B1 (fr) * | 2013-03-15 | 2017-11-15 | Iris International, Inc. | Procédé et composition permettant de colorer et de traiter un échantillon d'urine |
US9857361B2 (en) | 2013-03-15 | 2018-01-02 | Iris International, Inc. | Flowcell, sheath fluid, and autofocus systems and methods for particle analysis in urine samples |
US9771572B2 (en) | 2014-02-28 | 2017-09-26 | Gen-Probe Incorporated | Method of isolating nucleic acid from specimens in liquid-based cytology preservatives containing formaldehyde |
EP3670663A1 (fr) * | 2014-02-28 | 2020-06-24 | Gen-Probe Incorporated | Procédé pour isoler l'acide nucléique d'échantillons dans des conservateurs de cytologie aqueux contenant du formaldéhyde |
US9771571B2 (en) | 2014-02-28 | 2017-09-26 | Gen-Probe Incorporated | Method of isolating nucleic acid from specimens in liquid-based cytology preservatives containing formaldehyde |
JP2014158468A (ja) * | 2014-03-05 | 2014-09-04 | Clinical Genomics Pty Ltd | 検出方法 |
EP3725893A1 (fr) * | 2015-02-10 | 2020-10-21 | Illumina, Inc. | Compositions pour l'analyse de composants cellulaires |
US11168351B2 (en) | 2015-03-05 | 2021-11-09 | Streck, Inc. | Stabilization of nucleic acids in urine |
US20170145475A1 (en) | 2015-11-20 | 2017-05-25 | Streck, Inc. | Single spin process for blood plasma separation and plasma composition including preservative |
US10282588B2 (en) * | 2016-06-09 | 2019-05-07 | Siemens Healthcare Gmbh | Image-based tumor phenotyping with machine learning from synthetic data |
CN110456034B (zh) * | 2018-05-07 | 2022-07-22 | 上海市第十人民医院 | 一种循环肿瘤细胞的检测方法 |
CN109402240B (zh) * | 2019-01-08 | 2020-08-25 | 圣湘生物科技股份有限公司 | 核酸释放剂、核酸pcr扩增方法和pcr扩增试剂盒 |
WO2023080601A1 (fr) * | 2021-11-05 | 2023-05-11 | 고려대학교 세종산학협력단 | Procédé et dispositif de diagnostic de maladie faisant appel à une technologie d'imagerie par ombre sans lentille basée sur l'apprentissage machine |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5882864A (en) * | 1995-07-31 | 1999-03-16 | Urocor Inc. | Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
US6156515A (en) * | 1999-02-09 | 2000-12-05 | Urocor, Inc. | Prostate-specific gene for diagnosis, prognosis and management of prostate cancer |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4929556A (en) * | 1986-02-06 | 1990-05-29 | The Dow Chemical Company | Enzyme immobilization with polysulfonium salts |
US5346994A (en) * | 1992-01-28 | 1994-09-13 | Piotr Chomczynski | Shelf-stable product and process for isolating RNA, DNA and proteins |
EP0938320B2 (fr) * | 1996-03-26 | 2014-06-18 | Michael S. Kopreski | Procede permettant d'employer de l'arn extracellulaire extrait de plasma ou de serum a la detection, a la surveillance ou a l'evaluation d'un cancer |
US6156564A (en) * | 1996-06-07 | 2000-12-05 | The United States Of America As Represented By The Department Of Health And Human Services | Cellular apoptosis susceptibility protein (CSP) and antisense CSP |
KR100399475B1 (ko) * | 1998-02-12 | 2003-09-29 | 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 | 순환 중인 암세포의 신속하고 효과적인 분리 방법 및 이를위한 제제 |
US6358697B2 (en) * | 1999-04-21 | 2002-03-19 | Children's Hospital Medical Center | Intracellular pharmaceutical targeting |
-
2002
- 2002-10-28 CA CA002465274A patent/CA2465274A1/fr not_active Abandoned
- 2002-10-28 WO PCT/US2002/034397 patent/WO2003035894A2/fr not_active Application Discontinuation
- 2002-10-28 EP EP02795554A patent/EP1438398A2/fr not_active Withdrawn
- 2002-10-28 EP EP02795565A patent/EP1438419A2/fr not_active Withdrawn
- 2002-10-28 JP JP2003538395A patent/JP2005507997A/ja not_active Ceased
- 2002-10-28 WO PCT/US2002/034570 patent/WO2003035895A2/fr not_active Application Discontinuation
- 2002-10-28 AU AU2002360305A patent/AU2002360305A1/en not_active Abandoned
- 2002-10-28 CN CNA028261313A patent/CN1610752A/zh active Pending
- 2002-10-28 KR KR10-2004-7006181A patent/KR20040047971A/ko not_active Application Discontinuation
- 2002-10-28 CA CA002465288A patent/CA2465288A1/fr not_active Abandoned
- 2002-10-28 IL IL16135702A patent/IL161357A0/xx unknown
- 2002-10-28 BR BRPI0213520-5A patent/BR0213520A/pt unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5882864A (en) * | 1995-07-31 | 1999-03-16 | Urocor Inc. | Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
US6156515A (en) * | 1999-02-09 | 2000-12-05 | Urocor, Inc. | Prostate-specific gene for diagnosis, prognosis and management of prostate cancer |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8986966B2 (en) | 2002-09-27 | 2015-03-24 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
US9174222B2 (en) | 2005-04-05 | 2015-11-03 | The General Hospital Corporation | Devices and method for enrichment and alteration of cells and other particles |
US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
US8372584B2 (en) | 2006-06-14 | 2013-02-12 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
US9017942B2 (en) | 2006-06-14 | 2015-04-28 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US8168389B2 (en) | 2006-06-14 | 2012-05-01 | The General Hospital Corporation | Fetal cell analysis using sample splitting |
US9273355B2 (en) | 2006-06-14 | 2016-03-01 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US9347100B2 (en) | 2006-06-14 | 2016-05-24 | Gpb Scientific, Llc | Rare cell analysis using sample splitting and DNA tags |
US8296076B2 (en) | 2008-09-20 | 2012-10-23 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuoploidy by sequencing |
US8682594B2 (en) | 2008-09-20 | 2014-03-25 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US8195415B2 (en) | 2008-09-20 | 2012-06-05 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US9353414B2 (en) | 2008-09-20 | 2016-05-31 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US9404157B2 (en) | 2008-09-20 | 2016-08-02 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
Also Published As
Publication number | Publication date |
---|---|
KR20040047971A (ko) | 2004-06-05 |
IL161357A0 (en) | 2004-09-27 |
CA2465288A1 (fr) | 2003-05-01 |
EP1438419A2 (fr) | 2004-07-21 |
WO2003035894A3 (fr) | 2003-12-04 |
BR0213520A (pt) | 2006-05-23 |
CA2465274A1 (fr) | 2003-05-01 |
AU2002360305A1 (en) | 2003-05-06 |
CN1610752A (zh) | 2005-04-27 |
EP1438398A2 (fr) | 2004-07-21 |
JP2005507997A (ja) | 2005-03-24 |
WO2003035894A8 (fr) | 2004-06-03 |
WO2003035894A2 (fr) | 2003-05-01 |
WO2003035895A2 (fr) | 2003-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003035895A3 (fr) | Analyse a parametres multiples d'acides nucleiques complets et de caracteristiques morphologiques sur le meme echantillon | |
Goidin et al. | Ribosomal 18S RNA prevails over glyceraldehyde-3-phosphate dehydrogenase and β-actin genes as internal standard for quantitative comparison of mRNA levels in invasive and noninvasive human melanoma cell subpopulations | |
Keilholz et al. | Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: a quality-assurance initiative of the EORTC Melanoma Cooperative Group | |
AU767983B2 (en) | Methods for detecting nucleic acids indicative of cancer | |
WO2005098046A3 (fr) | Methodes de determination de biomarqueurs specifiques de cellules | |
CA2455731A1 (fr) | Methodes d'evaluation d'affections pathologiques utilisant un arn extracellulaire | |
CA2435917A1 (fr) | Methode tres sensible permettant de detecter les motifs de cytosine methylee | |
EP2816121A2 (fr) | Procédé permettant d'obtenir des informations sur le carcinome hépatocellulaire et marqueur et kit permettant d'obtenir des informations sur le carcinome hépatocellulaire | |
EP2357255A2 (fr) | Dépistage de la méthylation du gène GST-Pi | |
US20230366034A1 (en) | Compositions and methods for diagnosing lung cancers using gene expression profiles | |
WO2002079411A3 (fr) | Etablissement de profils d'expression genique dans un microreseau dans un adenocarcinome a cellules claires, pronostic et identification de cible medicamenteuse | |
Takano et al. | Quantitative measurement of thyroglobulin mRNA in peripheral blood of patients after total thyroidectomy | |
CN107475388B (zh) | 鼻咽癌相关的miRNA作为生物标志物的应用及鼻咽癌检测试剂盒 | |
EP2977467A2 (fr) | Procédé, utilisation de marqueur et dispositif de détermination pour obtenir des informations sur plusieurs types de cancers | |
JP2023109998A (ja) | マイクロサテライト不安定性の検出 | |
NO20032697L (no) | Teststrimmel assay system og assay metode for deteksjon og/eller bestemmelse av spesifikke nukleinsyresekvenser | |
EP2808397B1 (fr) | Procédé, marqueur et kit permettant d'obtenir des informations sur le cancer du côlon | |
CA2462932A1 (fr) | Methode de detection de la methylation de la cytosine dans des echantillons d'adn immobilise | |
CA2451483A1 (fr) | Methodes de detection et de surveillance du taux d'arn de cox-2 dans le plasma et le serum | |
WO1996021042A3 (fr) | Amorces destinees a l'amplification pcr de sequences metastatiques | |
CN100371459C (zh) | 细胞角蛋白19(CK19)mRNA荧光定量RT-PCR检测试剂盒 | |
US20080286784A1 (en) | Method for Detection of DNA Methyltransferase RNA in Plasma and Serum | |
US20040029117A1 (en) | Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the DNA | |
Krstulovic et al. | High performance liquid chromatographic determination of serum UV profiles of normal subjects and patients with breast cancer and benign fibrocystic changes | |
CN116219020A (zh) | 一种甲基化内参基因及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 161357 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002795565 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003538395 Country of ref document: JP Ref document number: 2465288 Country of ref document: CA Ref document number: 1020047006181 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002360316 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20028261313 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2002795565 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002795565 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0213520 Country of ref document: BR |